All material subject to strictly enforced copyright laws. © 2021 Euromoney Institutional Investor PLC group
Asia EquityAsia IPOs

Investors flock to Glenmark Life Sciences Rp15bn IPO

India_adobe_575x375_20

Glenmark Life Sciences, a pharmaceutical ingredients manufacturer, wrapped up a three-day bookbuild for its India IPO on Thursday. The deal, worth up to Rp15.5bn ($208.6m), was covered 15.5 times.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Take a Free Trial or Login
We use cookies to provide a personalized site experience.
By continuing to use & browse the site you agree to our Privacy Policy.
I agree